Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hugo Jourdain
Observed names:
H. Jourdain,
Hugo JOURDAIN
Institutions:
Conservatoire National des Arts et Métiers,
Agence Nationale de Sécurité du Médicament et des Produits de Santé,
Epi-Phare,
l'Assurance Maladie
Observed institutions:
Conservatoire National des Arts et Métiers,
Université Paris-Saclay,
Agence Nationale de Sécurité du Médicament et des Produits de Santé,
Centre Hospitalier Universitaire de Limoges,
Epi-Phare,
l'Assurance Maladie,
Hôpital Universitaire Dupuytren
show all 7
ORCID:
0000-0001-8035-7517
Observed ORCID:
0000-0001-8035-7517
OpenAlex ID:
A5065042314
Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study
2022
·
Hugo Jourdain
, Sophie Billioti de Gage
, et al.
·
The Lancet Public Health
·
125
PDF
Use and outcomes of trastuzumab deruxtecan in HER2-positive and HER2-low metastatic breast cancer in a real-world setting: a nationwide cohort study
2024
·
H. Jourdain
, A. Di Meglio
, et al.
·
ESMO Open
·
21
Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System
2024
·
Hugo Jourdain
, Léa Hoisnard
, et al.
·
RMD Open
·
18
PDF
TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
2022
·
Hugo Jourdain
, Léa Hoisnard
, et al.
·
Scientific Reports
·
18
PDF
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study
2023
·
Duc Binh Phan
, Hugo Jourdain
, et al.
·
BMJ Open
·
12
PDF
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System
2023
·
Hugo Jourdain
, Léa Hoisnard
, et al.
·
BioDrugs
·
11
PDF
PD-L1 inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: a French nationwide cohort study
2025
·
Hugo Jourdain
, Nicolas Albin
, et al.
·
The Lancet Regional Health - Europe
·
7
PDF
Vasectomy Procedures on the Rise in France From 2010 to 2022
2025
·
Noémie Roland
, Hugo Jourdain
, et al.
·
Perspectives on Sexual and Reproductive Health
·
7
PDF
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study
2025
·
Nadia Haddy
, Hugo Jourdain
, et al.
·
BioDrugs
·
7
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System
2025
·
Hugo Jourdain
, Léa Hoisnard
, et al.
·
World Journal of Pediatrics
·
7
PDF
Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study
2024
·
Duc Binh Phan
, Hugo Jourdain
, et al.
·
British Journal of Dermatology
·
7
Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies
2025
·
Hugo Jourdain
, Antonio Di Meglio
, et al.
·
The Lancet Regional Health - Europe
·
6
PDF
Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview
2023
·
Sophie Billioti de Gage
, Hugo Jourdain
, et al.
·
Therapies
·
6
Real-world use and survival outcomes of sacituzumab govitecan in metastatic triple-negative breast cancer and hormone receptor-positive/HER2-negative metastatic breast cancer
2026
·
Aya Elhusseiny Shaaban
, Hugo Jourdain
, et al.
·
British Journal of Cancer
·
5
PDF
Utilization and safety of trastuzumab emtansine (T-DM1): a nationwide population-based study using the French National Health Data System
2024
·
H. Jourdain
, I. Mansouri
, et al.
·
ESMO Real World Data and Digital Oncology
·
4
PDF
Overall survival according to COVID-19 mRNA vaccination co-exposure in patients treated with PD-(L)1 inhibitors: a French real-world cohort study
2026
·
H. Jourdain
, N. Haddy
, et al.
·
Annals of Oncology
·
2
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric Cancer in a Real-World Setting: A Nationwide Cohort Study
2024
·
Hugo Jourdain
, Nicolas Albin
, et al.
·
Clinical and Translational Gastroenterology
·
2
Évolution de la pratique de la vasectomie en France, à partir des données du Système national des données de santé (SNDS)
2024
·
N. Roland
, H. Jourdain
, et al.
·
Journal of Epidemiology and Population Health
·
2
Use of the injectable contraceptive medroxyprogesterone acetate in France in 2010–2023: A national descriptive study
2026
·
Noémie Roland
, Hugo Jourdain
, et al.
·
Therapies
·
1
Utilisation des biosimilaires des anti-TNF-alpha en France : une étude à partir des données du SNDS
2022
·
H. Jourdain
, L. Hoisnard
, et al.
·
Annales de Dermatologie et de Vénéréologie - FMC
·
1
Trends and Characteristics of Opioid Use During Pregnancy Between 2010 and 2023: A French Nationwide Drug Utilization Study
2026
·
Laurent Chouchana
, Philippe Herlemont
, et al.
·
European Journal of Pain
Création d’une application interactive d’exploration des données avec l’intelligence artificielle générative : étude de cas sur l’utilisation des anti-PD-(L)1 en France entre 2015 et 2024
2026
·
Hugo JOURDAIN
, David DESPLAS
, et al.
·
Journal of Epidemiology and Population Health
Utilisation en vie réelle et survie de sacituzumab govitecan dans les cancers du sein métastatiques triple-négatif et Hormono-positif /HER2−négatif
2026
·
Aya ELHUSSEINY SHAABAN
, Hugo JOURDAIN
, et al.
·
Journal of Epidemiology and Population Health
Use of lipid-lowering drugs in France over 10-years national study
2026
·
A. Gabet
, H. Jourdain
, et al.
·
Archives of cardiovascular diseases
Optimisation de la surveillance épidémiologique des produits de santé : de la donnée brute aux rapports standards automatisés
2025
·
Hugo JOURDAIN
, Jérôme DROUIN
, et al.
·
Journal of Epidemiology and Population Health
Show more works
View as search
Works count:
40
Citation count:
269
H-index:
7
I10-index:
6
Year
Topic
Type